ALX3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T human embryonic kidney cells. This heterogeneous pool carries diverse ALX3 gene disruptions introduced via CRISPR/Cas9, abolishing the function of the encoded homeobox transcription factor. The polyclonal format avoids clonal selection bias, offering a representative loss-of-function model for studying ALX3-dependent processes without requiring single-cell cloning. The targeted disruption of ALX3, a key regulator of craniofacial and neural crest development, enables dissection of its transcriptional networks in a tractable cell system.
The HEK293T cell line is a widely employed human embryonic kidney epithelial line stably expressing SV40 large T antigen, facilitating episomal replication of transfected plasmids and high-level protein expression. Derived from the HEK293 line via stable integration of the SV40 T antigen, HEK293T cells exhibit rapid growth, high transfection efficiency, and robust protein production, making them a premier host for viral packaging and recombinant protein generation. Their near-diploid karyotype and well-characterized signal transduction machinery support reliable CRISPR editing and downstream functional assays.
ALX3 is a paired-like homeodomain transcription factor that mediates craniofacial morphogenesis by integrating BMP, Wnt, and FGF signaling. BMP2/4 activate SMAD1/5 via BMPR1A/BMPR2, Wnt3a stabilizes ??-catenin through FZD/LRP5, and FGF8 signals via FGFR1 to MAPK1/3, all converging on ALX3 expression. ALX3 then interacts with cofactors MSX1, DLX2, CBP, and P300 to regulate downstream genes such as CDH1, SNAI1, MMP9, FOXD3, SOX9, and MSX2. This network governs epithelial-mesenchymal transition, cell migration, and neural crest specification.
Although HEK293T cells are not craniofacial in origin, they retain core BMP, Wnt, and MAPK pathway components, making them a useful reductionist system for dissecting ALX3 transcriptional function. The polyclonal knockout pool minimizes artifacts from individual clone-specific mutations, providing a more generalized loss-of-function background. HEK293T cells can be stimulated with recombinant BMP4, Wnt3a, or FGF8 to activate endogenous signaling cascades, and their high transfectability enables co-transfection of ALX3-interacting proteins for luciferase reporter assays, ChIP-qPCR of target promoters, and co-immunoprecipitation studies.
Research applications include investigating ALX3’s role in craniofacial gene regulation, neural crest biology, and frontonasal dysplasia. The knockout model supports assays such as RT-qPCR for target gene expression, western blotting for SMAD and MAPK activation, cell migration and EMT assays, and genome-wide RNA-seq and ChIP-seq. Co-immunoprecipitation with MSX1 or SMAD1 validates protein interactions, while flow cytometry can detect EMT marker changes. This polyclonal population is also suitable for pathway reconstitution experiments using BMP4, Wnt3a, or FGF8 stimulation. For inquiries or ordering, please contact Ascent Research.
